This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Peijun Chen Articles by Mellow, A. M. Search for Related Content PubMed PubMed Citation Articles by Peijun Chen, Articles by Mellow, A. M. Pubmed/NCBI databases Medline Plus Health Information Antidepressants Parkinson's Disease Patient Rights Veterans and Military Health Social Bookmarking                         What's this?

Antidepressant Treatment of Veterans With Parkinson's Disease and Depression: Analysis of a National Sample

Peijun.chen{at}med.va.gov

Helen C. Kales, MD

Daniel Weintraub, MD

Frederic C. Blow, PhD

Lan Jiang, MS

Alan M. Mellow, MD, PhD

We examined the impact of comorbid Parkinson's disease (PD) on depression treatment. Using national Veterans Affairs (VA) databases, fiscal year 2002 data were examined for 283 273 elderly males seen for depression. We compared 2 matched depression groups, one with (N = 7868) and one without (N = 7868) PD. In the 12-month period following a depression-related clinic visit, PD and non-PD patients were equally likely to fill an antidepressant prescription (77.8% vs. 77.4%), most commonly for a selective serotonin re-uptake inhibitor (SSRI) (62.9% vs 62.6%). Depressed PD patients had slightly higher rates of newer non-SSRI use (20.6% vs 19.2%, P < .05) and lower rates of tricyclic antidepressant use (7.4% vs 8.9%, P < .001). The presence of a PD diagnosis appears to have little impact on the frequency and type of antidepressant treatment. Efforts to improve the care of depressed PD patients should focus instead on improving recognition, ensuring adequacy of treatment, and evaluating the efficacy of existing antidepressants. (J Geriatr Psychiatry Neurol 2007;20:161-165)

Key Words: Parkinson's disease • depression • antidepressants

Journal of Geriatric Psychiatry and Neurology, Vol. 20, No. 3, 161-165 (2007)
DOI: 10.1177/0891988707301866


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. Menza, R. D. Dobkin, H. Marin, M. H. Mark, M. Gara, S. Buyske, K. Bienfait, and A. Dicke A controlled trial of antidepressants in patients with Parkinson disease and depression Neurology, March 10, 2009; 72(10): 886 - 892. [Abstract] [Full Text] [PDF]

				M. S. Okun and H. H. Fernandez Will tricyclic antidepressants make a comeback for depressed Parkinson disease patients? Neurology, March 10, 2009; 72(10): 868 - 869. [Full Text] [PDF]